ExoLab Italia Secures €5 Million in Series A Funding for Expansion
Deal News | Feb 18, 2025 | CDP Venture Capital
ExoLab Italia, a biotech firm specializing in exosome-based products, has raised €5 million in a Series A funding round. The funds were contributed by four investors: dsm-firmenich Ventures, CDP Venture Capital Sgr, Riello Investimenti Sgr's Linfa Fund, and Maia Ventures. With the funding, ExoLab Italia plans to scale up its industrial operations, expand internationally, and invest in talent acquisition. The company, founded in 2020 by leaders with deep expertise in oncology and molecular medicine, aims to leverage Italian organic resources to innovate in the cosmetic, pharmaceutical, and nutraceutical sectors. This strategic investment will aid in moving their facilities to increase production capacity significantly, supporting the firm's ambition to become a global leader in plant-based exosome innovation.
Sectors
- Biotechnology
- Cosmetics
- Pharmaceuticals
Geography
- Italy – ExoLab Italia is based in Italy, leveraging local organic agriculture for its exosome technology.
- Europe – ExoLab Italia plans to expand its market presence throughout Europe.
Industry
- Biotechnology – ExoLab Italia is a biotech company focusing on exosomes for cosmetics, pharmaceuticals, and nutraceuticals.
- Cosmetics – Part of ExoLab Italia's focus is on creating innovative cosmetic products using plant-based exosomes.
- Pharmaceuticals – ExoLab Italia is developing pharmaceutical applications for its exosome technology.
Financials
- €5 Million – Amount raised in the Series A funding round by ExoLab Italia.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| ExoLab Italia | Target Company | Companies | A biotechnology startup specializing in exosome-based products. |
| CDP Venture Capital Sgr | Investor | Companies | A private equity firm involved in the Series A funding round. |
| dsm-firmenich Ventures | Investor | Companies | An investment fund participating in ExoLab Italia's Series A round. |
| Riello Investimenti Sgr | Investor | Companies | Manager of the Linfa Fund contributing to the investment. |
| Maia Ventures | Investor | Companies | An investment fund involved in the funding round. |
| Gabriele Campi | CEO | People | CEO of ExoLab Italia. |
| Alessandro Scortecci | Chief Direct Investment Officer | People | Chief Direct Investment Officer at CdP Venture Capital Sgr. |
| Mariantonia Logozzi | Chief Technology Officer | People | Founder and Chief Technology Officer of ExoLab Italia. |
| Stefano Fais | Scientific Director | People | Founder and Scientific Director of ExoLab Italia. |
| Lorenzo Cilli | Chief Financial Officer | People | Chief Financial Officer of ExoLab Italia. |
| Valerio Carconi | Head of Marketing & Sales | People | Head of Marketing & Sales at ExoLab Italia. |
| Scientifica Venture Capital | Historical Investor | Companies | Early investor that supported ExoLab Italia's initial growth. |